- Home
- HOWL vs AMPG Comparison
HOWL vs AMPG Comparison
Compare HOWL & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- AMPG
- Stock Information
- Founded
- HOWL 2017
- AMPG 2002
- Country
- HOWL United States
- AMPG United States
- Employees
- HOWL N/A
- AMPG N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- AMPG Telecommunications Equipment
- Sector
- HOWL Health Care
- AMPG Telecommunications
- Exchange
- HOWL Nasdaq
- AMPG Nasdaq
- Market Cap
- HOWL 53.4M
- AMPG 46.7M
- IPO Year
- HOWL 2021
- AMPG N/A
- Fundamental
- Price
- HOWL $1.10
- AMPG $2.13
- Analyst Decision
- HOWL Strong Buy
- AMPG Strong Buy
- Analyst Count
- HOWL 3
- AMPG 1
- Target Price
- HOWL $8.33
- AMPG $5.00
- AVG Volume (30 Days)
- HOWL 648.5K
- AMPG 177.0K
- Earning Date
- HOWL 08-07-2025
- AMPG 08-13-2025
- Dividend Yield
- HOWL N/A
- AMPG N/A
- EPS Growth
- HOWL N/A
- AMPG N/A
- EPS
- HOWL N/A
- AMPG N/A
- Revenue
- HOWL $1,143,000.00
- AMPG $10,814,140.00
- Revenue This Year
- HOWL N/A
- AMPG $114.55
- Revenue Next Year
- HOWL N/A
- AMPG $50.00
- P/E Ratio
- HOWL N/A
- AMPG N/A
- Revenue Growth
- HOWL N/A
- AMPG N/A
- 52 Week Low
- HOWL $0.60
- AMPG $0.64
- 52 Week High
- HOWL $4.18
- AMPG $6.43
- Technical
- Relative Strength Index (RSI)
- HOWL 46.17
- AMPG 51.21
- Support Level
- HOWL $1.18
- AMPG $1.89
- Resistance Level
- HOWL $1.30
- AMPG $2.08
- Average True Range (ATR)
- HOWL 0.12
- AMPG 0.12
- MACD
- HOWL -0.03
- AMPG -0.02
- Stochastic Oscillator
- HOWL 6.33
- AMPG 39.22
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.